Atlas Venture
About Atlas Venture
Atlas Venture is a biotechnology company that creates and builds breakthrough biotechs, partnering with life science entrepreneurs to translate groundbreaking science into life-changing medicines.
Recent News
Diagonal Banks Another $125M for ‘Clustering’ Antibody Drugs
Do One Thing Every Day That Scares You
Why Owning the Learning Loop Matters More Than Owning the Lab
Lifordi Immunotherapeutics Inks New Funding
Triana Biomedicines Raises $120M in Series B Financing
Infinimmune Appoints Anthony Slavin, Ph.D., as Senior Vice President of Portfolio Strategy
Caldera Therapeutics Launches with $112.5M in Total Capital
Q32 Bio Raises $55M as Guardant, Soligenix, Novavax Lead Biotech Gains
Recent Deals
Kailera Raises $1bn in Growth-Stage Funding Round
Sunflower Labs Secures $16M Series B to Accelerate AI‑Driven Security Drones
Kailera Therapeutics Secures $600M Series B Funding Led by Bain Capital Private Equity
Triana Biomedicines Secures $120M Series B Funding Led by Ascenta Capital and Bessemer
Lifordi Immunotherapeutics Secures Strategic Investment From Sanofi Ventures, Raising Total to $112M